TY - JOUR
T1 - A bicyclic and hsst2 selective somatostatin analogue: design, synthesis, conformational analysis and binding
AU - Falb, Eliezer
AU - Salitra, Yoseph
AU - Yechezkel, Tamar
AU - Bracha, Moshe
AU - Litman, Pninit
AU - Olender, Roberto
AU - Rosenfeld, Rakefet
AU - Senderowitz, Hanoch
AU - Jiang, Shaokai
AU - Goodman, Murray
PY - 2001
Y1 - 2001
N2 - A backbone bridged and disulfide bridged bicyclic somatostatin analogue, compound 1 (PTR-3205), was designed and synthesized by solid-phase methodology. The binding of compound 1 to the five different somatostatin receptors, expressed in CHO or COS-7 cells, indicate a high degree of selectivity towards hsstr2. The three-dimensional structure of this compound has been determined in DMSO-d6 and in water by 1H NMR and by molecular dynamics simulations. Similar backbone conformations were observed in both solvents. We have established direct evidence that the backbone of this bicyclic somatostatin analogue assumes a ‘folded' conformation in solution, where the lactam ring extends roughly in the plane of the β-turn. The pharmacophoric region Phe-(d)-Trp-Lys-Thr of compound 1 is in accord with that of both the Veber compound L-363,301 (Merck) and sandostatin. We believe that the enhanced selectivity towards the hsst2 receptor, in comparison with other analogues, is due to its large hydrophobic region, composed of the lactam ring and the Phe side chains at positions 1 and 8.
AB - A backbone bridged and disulfide bridged bicyclic somatostatin analogue, compound 1 (PTR-3205), was designed and synthesized by solid-phase methodology. The binding of compound 1 to the five different somatostatin receptors, expressed in CHO or COS-7 cells, indicate a high degree of selectivity towards hsstr2. The three-dimensional structure of this compound has been determined in DMSO-d6 and in water by 1H NMR and by molecular dynamics simulations. Similar backbone conformations were observed in both solvents. We have established direct evidence that the backbone of this bicyclic somatostatin analogue assumes a ‘folded' conformation in solution, where the lactam ring extends roughly in the plane of the β-turn. The pharmacophoric region Phe-(d)-Trp-Lys-Thr of compound 1 is in accord with that of both the Veber compound L-363,301 (Merck) and sandostatin. We believe that the enhanced selectivity towards the hsst2 receptor, in comparison with other analogues, is due to its large hydrophobic region, composed of the lactam ring and the Phe side chains at positions 1 and 8.
UR - https://scholar.google.co.il/scholar?q=A+Bicyclic+and+Hsst2+selective+somatostatin+analog%3A+Design%2C+synthesis+conformational+analysis+and+binding&btnG=&hl=en&as_sdt=0%2C5
M3 - Article
VL - 9
SP - 3255
EP - 3264
JO - Bioorganic & medicinal chemistry
JF - Bioorganic & medicinal chemistry
IS - 12
ER -